7 people have now been reported dead due to blood clots using the AstraZeneca vaccine in the UK.

The Covid 19 vaccine, developed by Oxford University and AstraZeneca, has been the focus of attention around the world in recent weeks due to cases of blood clots or blood clots in people who use it in different countries.

Deaths due to Blood clots after AstraZeneca Vaccine
PC: Shutterstock

According to a BBC report, the medicine regulator has confirmed the deaths.

However, it is not yet clear whether the cases of blood clots are coincidental or whether the use of this vaccine has any side effects.

According to the UK’s Medicine and Healthcare Products Regulatory Agency (MHRA), the benefits of vaccines outweigh the risks.

The World Health Organization and the European Medicines Agency have issued similar statements regarding the AstraZeneca vaccine.

On the other hand, a spokesperson for AstraZeneca said that the safety of patients is the top priority of the company.

However, due to concerns about the vaccine in various countries, including Germany, France, the Netherlands and Canada, its use has been restricted to the elderly.

The MHRA released vaccine data on April 2, which reported 22 cases of a blood clot CVST related to the brain.

In this type of blood clot, the level of platelets decreases and the risk of bleeding increases, while 8 cases of blood clot were also discovered.

The MHRA confirmed that seven of the 30 were killed.

MHRA chief executive Dr John Raine said the benefits of the vaccine to prevent code 19 and its complications outweighed the risks and that the public should continue to use it.

The European Medicines Agency said a few days ago that the use of the AstraZeneca vaccine could lead to blood clots.

Under normal circumstances, about 16 out of every 1 million people suffer from blood clots, and the corona virus is also linked to the problem, which is probably why blood clots are becoming more common.

CVST cases and 9 deaths have been reported from 31 vaccine users in Germany, most of them reported in young or middle-aged women.

Leave a Reply